Health-Related Quality of Life in Older Patients With Advanced Heart Failure From Before to 2 Years After Heart Transplantation or Long-Term Mechanical Circulatory Support: Findings From the SUSTAIN-IT Study
Authors:
- Kathleen L. GradyKGKathleen L. Grady
- John A. SpertusJSJohn A. Spertus
- Mary Amanda DewMDMary Amanda Dew
- Tingqing WuTWTingqing Wu
- Scott SilvestrySSScott Silvestry
- Eileen HsichEHEileen Hsich
- Brent LampertBLBrent Lampert
- Michael PettyMPMichael Petty
- Salpy V. PamboukianSPSalpy V. Pamboukian
- Andrew KaoAKAndrew Kao
- James K. KirklinJKJames K. Kirklin
Open Access
- 1 November 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (11) , e013871
Abstract
BACKGROUND: Health-related quality of life (HRQOL) is a key consideration among older patients with heart failure considering advanced therapies. We evaluated change in HRQOL from before to 24 months after heart transplantation (HT) or long-term mechanical circulatory support (MCS) among older (60–80 years) patients and identified factors associated with HRQOL changes. METHODS: Data for this observational study were collected from 13 US sites via patient self-reported measures (EuroQol-5-dimension-3L visual analog scale score: 0=worst–100=best imaginable health state and dimension scores; Kansas City Cardiomyopathy Questionnaire-12 overall summary score/domain scores: 0–100, higher=better health status; other measures) and a 6-minute walk test. Analyses included multivariable linear mixed-effects models. RESULTS: Of 393 enrollees, 305 underwent surgery: HT with pretransplant MCS (HT MCS)=69, HT without pretransplant MCS (HT non-MCS)=92, and long-term MCS=144. Cohort average age=66.9±4.7 years, 78% male, 83% White, 78% married/partnered, and 71% with >high school education. HT non-MCS and long-term MCS groups experienced significant improvement in average visual analog scale scores within 6 months after surgery, sustained through 24 months of follow-up; the HT MCS group EuroQol-5-dimension-3L baseline visual analog scale score was higher than those of the other 2 groups and did not improve significantly through 24 months of follow-up. The average Kansas City Cardiomyopathy Questionnaire-12 overall summary score improved in all 3 groups (baseline–6 months, sustained through 24 months). Compared with HT non-MCS, the main effect of long-term MCS showed decrements of −11.2 (−17.3 to −5.1; P P =0.002) points in EuroQol-5-dimension-3L visual analog scale. CONCLUSIONS: HT MCS improvement in HRQOL varied by measure; HT non-MCS and long-term MCS improvement occurred through 24 months, regardless of measure. Domains of HRQOL improved after these surgeries, varying by surgical strategy and postoperative time period. Long-term MCS was associated with a decrease in HRQOL across time. These findings provide important information for patients considering treatment options.Keywords
This publication has 25 references indexed in Scilit:
- Impact of adverse events on health-related quality of life after left ventricular assist device implantation: An STS INTERMACS analysisThe Journal of Heart and Lung Transplantation, 2023
- How Does Age Affect Outcomes After Left Ventricular Assist Device Implantation: Results from the PCHF-VAD RegistryESC Heart Failure, 2022
- Differences in health-related quality of life by implant strategy: Analyses from the Interagency Registry for Mechanically Assisted Circulatory SupportThe Journal of Heart and Lung Transplantation, 2020
- Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation studyStatistics in Medicine, 2016
- Age and gender differences and factors related to change in health-related quality of life from before to 6 months after left ventricular assist device implantation: Findings from Interagency Registry for Mechanically Assisted Circulatory SupportThe Journal of Heart and Lung Transplantation, 2016
- Change in Health-related Quality of Life from Before to After Destination Therapy Mechanical Circulatory Support is Similar for Older and Younger Patients: Analyses from INTERMACSThe Journal of Heart and Lung Transplantation, 2014
- Older patients (age 65+) report better quality of life, psychological adjustment, and adherence than younger patients 5 years after heart transplant: A multisite studyThe Journal of Heart and Lung Transplantation, 2012
- Patterns and Predictors of Quality of Life at 5 to 10 Years After Heart TransplantationThe Journal of Heart and Lung Transplantation, 2007
- Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStatistics in Medicine, 1998
- Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaireQuality of Life Research, 1993